Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

NCT01168596 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Rasagiline
DRUG: Placebo

Sponsor

University of Florida